SEC Filings for Halozyme Therapeutics Inc. (HALO)

$ 30.83   -0.27 (-0.87%) Volume: 1.71m 4:00 PM EDT Oct 26, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities110/20/2020
4Statement of changes in beneficial ownership of securities109/21/2020
4Statement of changes in beneficial ownership of securities109/14/2020
4Statement of changes in beneficial ownership of securities109/04/2020
4Statement of changes in beneficial ownership of securities108/20/2020
4Statement of changes in beneficial ownership of securities108/14/2020
4Statement of changes in beneficial ownership of securities108/13/2020
8-KCurrent report pursuant to Section 13 or 15(d)908/10/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)7408/10/2020
4Statement of changes in beneficial ownership of securities107/20/2020
4Statement of changes in beneficial ownership of securities105/22/2020
4Statement of changes in beneficial ownership of securities105/21/2020
8-KCurrent report pursuant to Section 13 or 15(d)905/11/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)6005/11/2020
8-KCurrent report pursuant to Section 13 or 15(d)305/04/2020
<<
First
<
Prev
123456789101112131415